Lincoln Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹171.19Cr
Net Profits
₹26.33Cr
Net Profit Margins
15.38%
Highlights
Revenue:

Lincoln Pharmaceuticals Ltd’s revenue jumped 3.95% since last year same period to ₹171.19Cr in the Q2 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 8.56% jump in its revenue since last 3-months.

Net Profits:

Lincoln Pharmaceuticals Ltd’s net profit fell -4.77% since last year same period to ₹26.33Cr in the Q2 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 11.24% jump in its net profits since last 3-months.

Net Profit Margins:

Lincoln Pharmaceuticals Ltd’s net profit margin fell -8.4% since last year same period to 15.38% in the Q2 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 2.47% jump in its net profit margins since last 3-months.

FAQs

The revenue for Lincoln Pharmaceuticals Ltd in the Q2 results 2024 was ₹171.19Cr.

The net profit for Lincoln Pharmaceuticals Ltd in the Q2 results 2024 was ₹26.33Cr.

The net profit margin for Lincoln Pharmaceuticals Ltd in the Q2 results 2024 was 15.38%.

The revenue for Lincoln Pharmaceuticals Ltd in the Q2 results 2023 was ₹164.68Cr.

The net profit for Lincoln Pharmaceuticals Ltd in the Q2 results 2023 was ₹27.65Cr.

The net profit margin for Lincoln Pharmaceuticals Ltd in the Q2 results 2023 was 16.79%.